Ref ID: 18693
Author:
N. P. Wiederhold, PharmD – Associate Professor1,2, L. K. Najvar, BS – Laboratory Director 2,3, R. A. Bocanegra, BA – Research Associate 2,3, W. R. Kirkpatrick, MS – Project Coordinator 2,3, T. F. Patterson, MD – Professor 2,3, C. R. Thornton, PhD – S
Author address:
1UT Austin, Austin, TX, 2UTHSCSA, San Antonio, TX, 3STVHCS, San Antonio, TX, 4Univ. Exeter, Exeter, United Kingdom.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: The potential utility of a LFD for the early detection of IPA has been demonstrated (Wiederhold et al. Clin Vaccine Immunol 2009). Our objective was to evaluate the inter-laboratory (UT Austin and Univ. Exeter) and inter-study reproducibility of this LFD. Methods: An established neutropenic guinea pig model of IPA was used for pulmonary inoculation with Aspergillus fumigatus. At predetermined time points (1 hr, 3, 5, and 7 days post-inoculation) blood and BAL fluid were collected from infected and uninfected animals. An Aspergillus glycoprotein antigen was detected by each laboratory independently using an IgG monoclonal antibody-based LFD by applying 0.1mL of sample to the device. Galactomannan (GM) and (1,3)-β -D-glucan (BG) were measured using commercially available kits. The results were compared to those from a previous study. Results: Good inter-laboratory agreement was observed with the LFD. Overall, 96.7 % (29/30) of the serum and 73.3% (22/30) of the BAL samples from infected guinea pigs were in agreement between the two laboratories. The results for both serum and BAL samples from uninfected animals were 100% concordant. Good inter-study agreement was also found, as the LFD results observed in the current study were comparable to previous results (Table). In addition, the LFD results in both serum and BAL were similar to those observed with the BG and GM assays. Conclusions: These results demonstrate that the LFD assay is reproducible between different laboratories and studies. This assay leads to consistent and specific results with serum and BAL fluid for the detection of IPA.
Abstract Number: M-1682
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a